BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 8584584)

  • 1. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
    Bhargava HN; Matwyshyn GA; Gudehithlu KP
    Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
    Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
    Pharmacol Biochem Behav; 1994 May; 48(1):87-91. PubMed ID: 8029307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
    Bhargava HN; Kumar S
    Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Gen Pharmacol; 1995 Sep; 26(5):1055-60. PubMed ID: 7557250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna ; Reddy PL; Bhargava HN
    Eur J Pharmacol; 1993 Apr; 235(1):23-30. PubMed ID: 8390939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
    Bhargava HN; Thorat SN
    Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN; Gulati A; Ramarao P
    Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
    Bhargava HN; Thorat SN
    Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
    Bhargava HN; Gulati A; Ramarao P
    Biochem Pharmacol; 1991 Jun; 42(1):25-9. PubMed ID: 1648922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN; Gulati A; Rahmani NH
    Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of kappa opioid mediated effects in the rat by cyclo(Leu-Gly).
    Bhargava HN; Ramarao P
    Life Sci; 1989; 45(26):2521-8. PubMed ID: 2559273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
    Thorat SN; Veeranna ; Reddy PL; Bhargava HN
    Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DPAT to 5-HT1A receptors in the hypothalamus of the rat.
    Reddy VP; Bhargava HN
    Neuropharmacology; 1992 Dec; 31(12):1243-9. PubMed ID: 1470300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Pharmacology; 1994 Apr; 48(4):234-41. PubMed ID: 7513892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat.
    Gulati A; Ramarao P; Bhargava HN
    Pharmacology; 1989; 39(3):145-53. PubMed ID: 2587620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.